The global Digital PCR Market accounted for $318.2 million in 2017 and is expected to garner $1,206.5 million by 2025, growing with a CAGR of 18.0% through 2025.
Increased demand for novel diagnostic techniques and surge in health awareness are the major drivers of the global digital PCR market. However, limited expertise and accessibility in the developing economies and high cost of digital PCR testing hamper the market growth. On the other hand, increase in number of diagnostic centers across the world and dire need for early diagnosis of viral, genetic, and infectious disease are expected to create remunerative opportunities for the market players in the coming years.
Get Sample Report @ https://www.alliedmarketresearch.com/request-sample/654
The report spits into technology, product type, application, end user, and geography. The technology segment is divided into droplet digital PCR (ddPCR) and BEAMing digital PCR. The droplet dPCR segment is the most dominant and held about four-fifths of total market share in 2017. However, the BEAMing digital PCR segment is expected to portray the fastest CAGR of 18.9% through 2025, owing to high sensitivity that helps to identify and quantify specific somatic mutations present in DNA and growing awareness regarding the benefits of using this technology.
Based on product type, the report bifurcates into digital PCR equipment, consumables & reagents, and software & services. The software & services segment is estimated to manifest the fastest CAGR of 19.9% during the forecast period. Conversely, the consumables and reagents segment dominated the market in 2017, contributing more than half of the total share.
On the basis of application, the report splits into clinical diagnostics, research, and forensics. The research segment held the largest share in 2017, accounting about one-third of the total revenue. However, the forensics segment is projected to portray the fastest CAGR of 18.8% through 2025.
Based on region, the report divides into Asia-Pacific, Europe, North America, and LAMEA. The Asia-Pacific region is estimated to manifest the fastest CAGR of 17.7% during the forecast period, owing to rise in number of patients with chronic diseases and improved healthcare infrastructure in the region. On the other hand, North America would retain the highest market share throughout the forecast period, owing to rise in patients that use personalized medicines and presence of leading molecular diagnostics.
Ask for More Details @ https://www.alliedmarketresearch.com/purchase-enquiry/654
The report analyzes the major market players such as Bio-Rad Laboratories, Inc. (RainDance Technologies, Inc.), Qiagen N.V. (Formulatrix, Inc.), Sysmex Corporation (Sysmex Inostics GmbH), Merck KGaA, Thermo Fisher Scientific, Inc., JN Medsys, Qiagen N.V. (Formulatrix, Inc.), Fluidigm Corporation, and Stilla Technologies.
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060